The European pharmaceutical industry, represented by EFPIA and EGA, and the European biotechnology industry represented by EuropaBio, note with concern the recent decision of the European Commission to cut the amount of funding earmarked for the scientific community via the EU's flagship Research and Innovation programme, Horizon 2020.
“We welcome that, after a standstill of one year and half, the European Commission has finally decided to authorise imports of safe products in accordance with democratically agreed procedures and with scientific evidence”
“The European Commission is sacrificing the fundamental principle of the internal market by proposing to set up a patchwork of national bans on imports of safe products”, said Jeff Rowe, Chairman of the Agri-Food Council of EuropaBio.
The EU Food and feed chain partners urged European Commission President Juncker today to reject any attempt to renationalize EU market authorisations of genetically modified crops for feed and food use.
EuropaBio and the Deerfield Institute have partnered to carry out a survey on the current state of regulatory and health technology assessment (HTA) advice with a special focus on small and medium sized enterprises (SMEs).